Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has issued an update.
Recce Pharmaceuticals Ltd announced a proposed issue of securities, including warrants and ordinary shares, set to be issued by the end of 2025. This strategic move aims to bolster the company’s financial resources, potentially enhancing its market position and operational capabilities in the pharmaceutical sector.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of novel antibiotics. The company is involved in producing anti-infective drugs aimed at addressing the growing issue of antibiotic resistance.
Average Trading Volume: 214,547
Technical Sentiment Signal: Sell
Current Market Cap: A$90.84M
See more data about RCE stock on TipRanks’ Stock Analysis page.